金斯瑞生物科技(01548.HK)轮值首席执行官辞任

阿斯达克财经
02 Dec 2024

金斯瑞生物科技(01548.HK) 公布,柳振宇辞去轮值首席执行官、制裁风险控制委员会成员、全资附属公司CustomArray Inc.董事,于本月31日生效。
另外,柳振宇亦已提交辞呈辞去非全资附属公司Probio Technology Limited董事会主席职务,于昨日(1日)生效。(js/w)

(港股报价延迟最少十五分钟。沽空资料截至 2024-11-29 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10